, , , , , , , , , ,

In the aftermath of the recent meningitis outbreak crisis, a number of legislators are aiming to strengthen the oversight of compounding pharmacies. The Maryland State Board of Pharmacy defends its position on regulating compounding pharmacies in its state, in an article published by the Baltimore Sun. The article includes quotes from the Maryland Board of Pharmacy’s Executive Director Laverne Neasea, and state epidemiologist Dr. David Blythe, who testified during a legislative hearing on compounding pharmacies last week. Click here to view article in its entirety.